Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.


BACKGROUND Chemotherapy treated cancer patients are prone to neutropaenia and life-threatening infections. Early, empirical antibiotic treatment is therefore administered routinely to febrile neutropaenic patients. Currently, either beta-lactam-aminoglycoside combination treatment or beta-lactam monotherapy are recommended. OBJECTIVES We compared beta… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.